ACR 2017 The Crossroads of Radiology

ACR2017VM03 - Lung Nodules and Cancer Screening

May 21, 2017 10:00am ‐ May 21, 2017 12:00pm


The purpose of this session is to discuss lung cancer screening programs and to highlight challenges that may arise as the programs mature. Following the publication of the National Lung Screening Trial and subsequent USPSTF and CMS recommendations and coverage decisions, more and more practices and institutions are implementing CT lung cancer screening programs. The session will provide information on how to continue forward with lung cancer screening beyond just establishing a program. Topics include correctly using Lung-RADS, addressing 'gaps' in Lung-RADs, managing the screening process after the baseline screen, and implementing upcoming changes in the Fleischner Society recommendations for management of incidentally detected lung nodules. Developed in conjunction with The Fleischner Society and Society of Thoracic Radiology.

Learning Objectives:

  1. Identify solutions to common challenges encountered in establishing a lung cancer screening program.
  2. Discuss appropriate management recommendations and correctly use Lung-RADS to report lung cancer screening CT scans.
  3. Describe changes to lung nodule management based on the 2017 Fleischner Society guidelines.



  • Geoffrey Rubin, MBA, MD, FACR - Consultant - GE Healthcare|Fovia, Inc.; Stock Options - HeartFlow
  • Ella Kazerooni, MD, MS, FACR FSCBTMR - This speaker has nothing to disclose
  • Jeffrey Kanne, MD - Consultant - Parexel International|HealthMyne
  • Florian Fintelmann, MD, FRCPC - Consultant - McKesson
  • Maria Martin, MD - This speaker has nothing to disclose
  • Jared Christensen, MD - Consultant- Riverain Technologies, LLC

You must be logged in and own this session in order to post comments.